The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
Open accessAbstract
Background: Many adults eligible for statin therapy for cardiovascular disease prevention are untreated. Our objective was to investigate patient‐reported reasons for statin underutilization, including noninitiation, refusal, and discontinuation. Methods and Results: This study included the 5693 adults recommended for statin therapy in the PALM (Patient and Provider Assessment of Lipid Management) registry. Patient surveys evaluated statin experience, reasons for declining or discontinuing statins, and beliefs about statins and cardiovascular disease risk. Overall, 1511 of 5693 adults (26.5%) were not on treatment. Of those not on a statin, 894 (59.2%) reported never being offered a statin, 153 (10.1%) declined a statin, and 464 (30.7%) had discontinued therapy. Women (relative risk: 1.22), black adults (relative risk: 1.48), and those without insurance (relative risk: 1.38) were most likely to report never being offered a statin. Fear of side effects and perceived side effects were the most common reasons cited for declining or discontinuing a statin. Compared with statin users, those who declined or discontinued statins were less likely to believe statins are safe (70.4% of current users vs. 36.9% of those who declined and 37.4% of those who discontinued) or effective (86.3%, 67.4%, and 69.1%, respectively). Willingness to take a statin was high; 67.7% of those never offered and 59.7% of patients who discontinued a statin would consider initiating or retrying a statin. Conclusions: More than half of patients eligible for statin therapy but not on treatment reported never being offered one by their doctor. Concern about side effects was the leading reason for statin refusal or discontinuation. Many patients were willing to reconsider statin therapy if offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a registry that studied reasons why eligible patients were not taking a statin, 59% reported never being offered treatment, 10% declined a statin, and 31% discontinued therapy.18”
From Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationA Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,920
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,781
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Self-citationAdherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
Persistence of Use of Lipid-Lowering Medications
Avorn, J., Monette, J., Lacour, A. S., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998) · JAMA · doi:10.1001/jama.279.18.1458 · Cited by 635
Application of New Cholesterol Guidelines to a Population-Based Sample
Pencina, M. J., Navar‐Boggan, A. M., D’Agostino, R. B., Williams, K., Neely, B., Sniderman, A. D., & Peterson, E. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315665 · Cited by 612
Self-citationNissen, S. E., Stroes, E., Dent-Acosta, R. E., Rosenson, R. S., Lehman, S. J., Sattar, N., Preiss, D., Bruckert, E., Ceška, R., Lepor, N., et al. (2016) · JAMA · doi:10.1001/jama.2016.3608 · Cited by 522
Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials
Kashani, A., Phillips, C. O., Foody, J. M., Wang, Y., Mangalmurti, S., Ko, D. T., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.106.624890 · Cited by 474
Cited by
Sorted by citations
Items 201–286 of 286
Al-Dalakta, A., Honnekeri, B., Rodríguez, F., Laffin, L. J., Sunder, V., Bruemmer, D., Cho, L., Nissen, S. E., & Sarraju, A. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101404 · Cited by 1
Nguyen, D. Q., Hwang, J., Rohatgi, A. K., Joshi, P. H., Khera, A., Peterson, E. D., & Návar, A. M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101421 · Cited by 1
Self-citationMarnell, C. S., Koenig, W., Bittner, V., Watson, K. E., Muntner, P., Nordestgaard, B. G., Yan, L. L., Verbakel, M., & Rosenson, R. S. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012330 · Cited by 1
Letter regarding “Female Patients Receive Less Medical Therapy”
Li, X., & Li, P. (2026) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.10.095 · Cited by 1
Muzambi, R., Bhaskaran, K., Strongman, H., van Staa, T. P., Smeeth, L. L., Suffel, A. M., & Herrett, E. L. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-002618 · Cited by 5
Discontinuation of statin therapy – an updated review
Orfanos, E., Byun, J. H., & Daskalopoulou, S. S. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001316 · Cited by 1
Pharmacists must take an active role as citizen scientists
Brazeau, G. A., Robinson, E. T., Reardon, G., & Zgarrick, D. P. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.10.009 · Cited by 1
Lau, D., Pearson, G. J., Raggi, P., & Klarenbach, S. W. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15558 · Cited by 1
Initial non-adherence to lipid-lowering medication: a systematic literature review
Cooke, C. E., & Robertson, T. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02524-z · Cited by 1
Simony, S. B., Langsted, A., Mortensen, M. B., Nordestgaard, B. G., & Afzal, S. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118625 · Cited by 1
Vikulova, D. N., Lee, M. K., Humphries, K. H., Pinheiro-Muller, D., Dawes, M. G., Pimstone, S. N., & Brunham, L. R. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101316 · Cited by 1
Landmesser, U., Laufs, U., Schatz, U., Winzer, E. B., Nowak, B., Kassner, U., Gouni‐Berthold, I., Esteban, A., Lubyayi, L., Krueger, A., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.05.014 · Cited by 1
The insidious impact of under-diagnosed proximal weakness induced by statins
Dobkin, B. H. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1866988 · Cited by 1
Inclisiran: Small Interfering Ribonucleic Acid Injectable for the Treatment of Hyperlipidemia
Hughes-Hubley, F., Iskander, M., Cheng-Lai, A., Frishman, W. H., & Nawarskas, J. J. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000452 · Cited by 1
Shoup, J. P., Kim, A., Wilson, J. A., Pendergast, J., Ranard, B. L., & Boggan, J. C. (2022) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000352 · Cited by 1
Safarova, M. S., Moriarty, P. M., Kullo, I. J., Ballantyne, C. M., & Gianos, E. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.027 · Cited by 1
Lowenkamp, M. N., & Reitz, K. M. (2026) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.11.018 · Cited by 1
Gharibyan, I., Ahner, E., Shao, R., Sharma, D., Tazehkand, T. N., Diep, J., & Assoumou, B. O. M. T. (2026) · medRxiv · doi:10.64898/2026.06.04.26354962 · Cited by 1
The Patient Perspective on Statin-Associated Muscle Symptoms
Brinton, E. A. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-33304-1_5
A Framework for Online Public Health Debates: Some Design Elements for Visual Analytics Systems
Ninkov, A., & Sedig, K. (2022) · Information · doi:10.3390/info13040201
Statins underutilised, refused and discontinued by patients
(2019) · PharmacoEconomics & Outcomes News · doi:10.1007/s40274-019-5795-8
Statins underutilised, refused and discontinued by patients
(2019) · Reactions Weekly · doi:10.1007/s40278-019-59652-2
Nandiwada, S., Manca, D. P., Yeung, R. O., & Lau, D. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220673-f
Statins In High Risk Populations For Primary And Secondary Prevention, Do We Need To Do More?Preprint
Kitchlew, R., Mukhtar, H., Farooqi, M., Ijaz, M. T., & Aslam, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-3864377/v1
CT calcium score testing for early detection of coronary artery disease
Campbell, K., Harber, A., Jennings, J., & Smiley, L. (2024) · The Nurse Practitioner · doi:10.1097/01.npr.0000000000000140
Anta, L. D., Álvarez-Mon, M. Á., Pereira-Sánchez, V., Donat‐Vargas, C., Abelanda, F. L., Arrieta, M., Montero-Torres, M., Montero, C. G., Fraile‐Μartinez, O., Mora, F., et al. (2024) · doi:10.2196/preprints.57394
Familial hypercholesterolaemia: a genetic condition with associated cardiovascular risk
Neves, E., Bueser, T. ‘., Frampton, K., Lee, E. J., Studart, D., Tobin, L., & Wilson, E. M. (2024) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2023.0024
Orringer, C. E. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.03.412
Scherer, L. D., Lin, G. A., & Kini, V. (2024) · PEC Innovation · doi:10.1016/j.pecinn.2024.100303
Gbaa, T. T., & Bolodeoku, J. (2024) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2024.6.e11
van Lennep, J. E. R., & Holven, K. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-65952-2_5
Izquierdo, B. G., Martínez‐Urbistondo, D., Guadalix, S., Pastrana, M., Buenestado, A. B., Colina, I., de Yébenes, M. G., Bastarrika, G., Páramo, J. A., & Delgado, J. P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041218 · Cited by 1
Preventive, Therapeutic, and Palliative Care
Karhausen, L. (2025) · Philosophy and medicine · doi:10.1007/978-3-031-81257-6_14 · Cited by 1
Cai, T., Hirst, J. A., Nicholson, B. D., McManus, R. J., Hobbs, F. D. R., Sheppard, J. P., & Koshiaris, C. (2026) · The Lancet Digital Health · doi:10.1016/j.landig.2026.101024
Increasing statin prescribing through a pharmacogenomics-guided initiative
Rennie, C., Roads, M., Bright, B., Armstrong, S., & Reid, J. M. (2025) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2025.102898
Byrd, K. K., Tie, Y., Lin, C. Y.-C., Kuo, Y., Beer, L., O’Connor, S., Buchacz, K., Luo, F., & Weiser, J. K. (2025) · AIDS · doi:10.1097/qad.0000000000004385
Rethinking Statin Dosage in Coronary Disease
Dimmitt, S. B., Stampfer, H. G., Kennedy, M., & Martin, J. H. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70187
Lim, H. M., Ng, C. J., Abdullah, A. B., & Dunn, A. G. (2023) · Figshare · doi:10.6084/m9.figshare.24564188
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821096
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821087
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821102
Carbonell-Soliva, Á., Nouni-García, R., López‐Pineda, A., Fort, A. C., Pérez‐Jover, V., Quesada, J. A., Orozco‐Beltrán, D., Nolasco, A., Castellano-Vázquez, J. M., Mira-Solves, J. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26681800
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821093
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821099
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821105
Carbonell-Soliva, Á., Nouni-García, R., López‐Pineda, A., Fort, A. C., Pérez‐Jover, V., Quesada, J. A., Orozco‐Beltrán, D., Nolasco, A., Castellano-Vázquez, J. M., Mira-Solves, J. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26681803
Weeda, E. R., Bishu, K. G., Ward, R. C., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020) · Figshare · doi:10.6084/m9.figshare.13100913
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821084
Lim, H. M., Ng, C. J., Abdullah, A. B., & Dunn, A. G. (2024) · Figshare · doi:10.6084/m9.figshare.24564287
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821090
Carbonell-Soliva, Á., Nouni-García, R., López‐Pineda, A., Fort, A. C., Pérez‐Jover, V., Quesada, J. A., Orozco‐Beltrán, D., Nolasco, A., Castellano-Vázquez, J. M., Mira-Solves, J. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26681806
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821081
Muck, M. A., Fischer, M., Hamerle, M., Strack, C., Holzhaeuer, M., Pfeffer, D., Hubauer, U., Maier, L. S., & Baessler, A. (2024) · Figshare · doi:10.6084/m9.figshare.26944998
Hofmann, M., Berger, T., & Weiss, P. (2022) · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology · doi:10.51847/wyrmvx9kyk
Sönnerstam, E., Holmberg, H., Carlberg, B., Norberg, M., Själander, A., & Glader, E. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100924
Vordenberg, S. E., Dulo, N., Bonner, C., Ferguson, E. M., Marshall, V. D., & Weir, K. R. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70440
Wright, A. P., Choi, L., Nairon, K. G., Gatto, C. L., Dear, M. L., Winkle, G. V., Lagalante, S., Neal, E. B., Wright, A., & Rice, T. W. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-108123
Guadagni, A. J., Paton, C. M., & Cooper, J. A. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101396
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems
Shah, N. P., Peterson, E. D., Shrader, P. J., Shoji, S., Freeman, N. L. B., Martin, S. S., Allred, C., Fernandez, S. A., Chamberlain, A. M., Arnold, J., et al. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012622
Self-citationA Review of Traditional and Non-Traditional Cardiovascular Risk Factors in Women
Vasanthakumar, S. A., Paleri, S., Aldous, E., Khanna, S., Nandurkar, R., Davis, E., Lin, A., & Nerlekar, N. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s574244
Tipnoppanon, S., Siwamogsatham, S., Vorasettakarnkij, Y., Sukasem, C., Chariyavilaskul, P., Satapornpong, P., & Vanwong, N. (2026) · Clinical and Translational Science · doi:10.1111/cts.70528
Glud, M., Krarup, N. T., Juhl, C. B., Stenholt, L., Andersen, J. K., Nielsen, L. H., & Dahl, M. L. N. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109666
EHR-derived cognitive load is associated with guideline-concordant statin initiation in primary care
Viswanadham, R. V. N., Cui, Y. B., Solanki, P., Redfern, N., Shunk, A., Mastrianni, A., Levine, D. L., Mann, D. M., & Richardson, S. I. (2026) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-026-03392-6
Unmet needs for lipid management in patients with peripheral arterial disease: A narrative review
Bolden, D. M., Cheeley, M. K., & Tedder, B. C. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.04.016
Cardoso, R. N., Besser, S. A., Petranović, M., Huck, D. M., Shiyovich, A., Freire, C. V. S., Biery, D. W., Brown, C. J., Shah, N., Turchin, A., et al. (2026) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2026.03.013
Lundgren, T. L., Glader, E., Holmberg, H., Norberg, M., Själander, A., & Sönnerstam, E. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05922-6
Real-world experience in the management of lipids in patients after an acute coronary syndrome
Shariff, O., Madhotra, R., Nair, A., Tennyson, R., Bhagania, A., Ullah, H., Enver, M., & Nadar, S. K. (2026) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2026.05.001
Pätzold, D., Vonbank, A., Clodi, M., Sourij, H., Hübner, D., Ebenbichler, C. F., Fagan, A., Farries, G., Hofstätter, E., Nitzlader, M., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.07.025
Ali, A. H., Tak, K. A., Taylor-Yeremeeva, E. M., Shao, C., Shao, C., Fandino-Rubio, N., Jerome, M., Lessard, D., Kiefe, C. I., McManus, D. D., et al. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-03017-x
Szendrei-Lódi, R., Tömő, Z., Beke, S., & Márk, L. (2026) · Orvosi Hetilap · doi:10.1556/650.2026.33612
Denial of Access as an Unmeasured Outcome in Nonprescription Statin Self-Selection StudiesPreprint
Molinari, K. P. (2026) · medRxiv · doi:10.64898/2026.09.06.26362346
Bempedoic Acid: From Guidelines to the Real World
Zimodro, J. M., & Gouni‐Berthold, I. (2026) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2026.15.3.381
Rehman, M. A., Oduoye, M. O., Ozoemena, D. J., Danso, E. A., Chukwuka, G., & Odelade, M. A. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1911458
Šimičević, L., Ganoci, L., Karačić, E., Božina, T., Pećin, I., Trkulja, V., & Božina, N. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1840055
Azeem, A., & Huynh, C. (2026) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2026.09.042
Early Detection of Metabolic-Dysfunction Associated Steatotic Liver Disease Using FIB-4
Low, Y. L. (2026) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-83742-662-120261020
Jacobs, J., Herbst, W., Burka, S., Tajrishi, F. Z., Tsakiris, E., Wright, L. A., & Ferdinand, K. C. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.102561
Cardiovascular Complications of Chronic Liver Disease
Park, S., Gupta, D. K., Izzy, M. J., & VanWagner, L. B. (2026) · Circulation · doi:10.1161/circulationaha.126.079443
Metadata
- Authors
- Bradley, C. K., Wang, T. Y., Li, S., Robinson, J. G., Roger, V. L., Goldberg, A. C., Virani, S. S., Louie, M. J., Lee, L. V., Peterson, E. D., & Navar, A. M.
- Affiliations
- Duke University (US)
- University of Iowa (US)
- Mayo Clinic (US)
- Washington University in St. Louis (US)
- Baylor College of Medicine (US)
- Regeneron (United States) (US)
- Sanofi (United States) (US)
- Department of Medicine and Duke Clinical Research Institute Duke University School of Medicine Durham NC
- Corresponding author
- Bradley, Corey K.
- ORCID
- Venue
- Journal of the American Heart Association
- Published
- 2019-04-02
- Volume
- 8
- Issue
- 7
- Pages
- e011765-e011765
- ISSN
- 2047-9980 (ISSN-L)
- PMC
- PMC6509731
- OpenAlex
- W2923928888
- Cited by
- 286
- References
- 25
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 56 · 2023: 43 · 2022: 30 · 2021: 41 · 2020: 28 · 2019: 13
- FWCI
- 26.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of the American Heart Association (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- eCommons - AKU (Aga Khan University) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K01HL133416)
- Duke Clinical Research Institute
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- statin therapy, statin discontinuation, fear of side effects, cardiovascular disease prevention, lipid control, health beliefs, racial and ethnic disparities, insurance status
- MeSH terms
- Patient Reported Outcome Measures, Adult, Aged, Attitude to Health, Black or African American, Cardiovascular Diseases, Fear, Female, Humans, Male, Middle Aged, Motivation, Practice Patterns, Physicians', Primary Prevention, Registries, Sex Factors, United States, Treatment Refusal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, White People, Atherosclerosis, Healthcare Disparities, Medication Adherence, Secondary Prevention, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
